Article Information
History
- May 26, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Allison Y. Zhong1,
- Leonardino A. Digma1,
- Troy Hussain1,
- Christine H. Feng1,
- Christopher C. Conlin2,
- Karen Tye1,
- Asona J. Lui1,
- Maren M.S. Andreassen3,
- Ana E. Rodríguez-Soto2,
- Roshan Karunamuni1,
- Joshua Kuperman2,
- Christopher J. Kane4,
- Rebecca Rakow-Penner2,
- Michael E. Hahn2,
- Anders M. Dale2,5 and
- Tyler M. Seibert1,2,6,*
- 1Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA
- 2Department of Radiology, University of California San Diego, La Jolla, CA, USA
- 3Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway
- 4Department of Urology, University of California San Diego, La Jolla, CA, USA
- 5Department of Neurosciences, University of California San Diego, La Jolla, CA, USA
- 6Department of Bioengineering, University of California San Diego, La Jolla, CA, USA
- ↵* Corresponding author; email: tseibert{at}ucsd.edu
Posted May 26, 2021.
Patient-level detection of grade group ≥2 prostate cancer using quantitative diffusion MRI
